A robust reduction in serum ACE2 activity was found in parallel to the improving cardiac performance and function called reverse remodeling (HF - CRT after: to 34.3±1.9 UF/mL; P<0.001, Figure 4A). The gene discussed is ACE2; the disease is hydrops fetalis.